RE:RE:RE:Money Coming InOh trust me, I understand it. Having a larger top line is more important than most people think id growing and develloping a company quickly, like this entire sector is trying to do. canopy has said from day 1 that proffiability is not a core focus of theirs at this point. Sure some of the additional revenues comes with additional COGS. The product operating margin though should be positive, meaning that the millions of dollars left over and above the variable cost of production can be spent on growth. This can be staffing, having more staff ofter leads to greater breakthroughs, less mistakes, proper handling and QA. It can also be facilities expansion and equiptment. Many things go in an income statement. It can be R&D expenses or marketing. All of these things are subtracted after the operating margin but before the EBITDA and help your company grow. These areas as well as many more, canopt is able to invest in a lot more without taking on debt or raising money. That early push for a positive EBITDA is likely the reason for Aphira's stagnation in revenues.
Please be a bit more humble before saying others don't know what they are doing.